EGFR and central nervous system cancer: The results show that they are mainly enriched in the following: circadian rhythm, AMPK signaling pathway, valine, leucine, and isoleucine biosynthesis, longevity regulatory pathway—multiple species, acute myeloid leukemia, melanoma, PPAR signaling pathway, circadian rhythm—fly, glioma, and EGFR tyrosine kinase inhibitor resistance.